Search

everythinglearnresearchcommunity

for

Search:↓

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

New genes found linked to balding, may help develop future treatments.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Bee venom might be a good alternative treatment for various skin conditions because it has many healing properties.

Androgens may block hair growth signals, targeting this could treat hair loss.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.